Defibrillation Testing and Early Neurologic Outcome

• Published in: International Heart Journal Vol. 49; no. 5; pp. 553 - 563
• Main Authors: Karaoguz, Remzi, Altln, Timuein, Atbasoglu, E. Cem, Isikay, Canan, Güraslan, Bahar, Akyürek, Ömer, Beton, Osman, Vurgun, Kutay, Yüceman, Nezih, Soylu, Kazim, Güldal, Muharrem
• Format: Journal Article
• Language: English
• Published: Japan International Heart Journal Association 2008
• Subjects: Aged; Cognition - physiology; Cognitive function; Defibrillators, Implantable; Electric Countershock - adverse effects; Equipment Safety; Female; Follow-Up Studies; Humans; Implantable cardioverter defibrillator; Male; Middle Aged; Nervous System - physiopathology; Neurologic Examination; Neuron specific enolase; Neuronal injury; Phosphopyruvate Hydratase - blood; Treatment Outcome; Ventricular Fibrillation - enzymology; Ventricular Fibrillation - etiology; Ventricular Fibrillation - psychology
• DOI: 10.1536/ihj.49.553
• ISSN: 1349-2365

During implantable cardioverter-defibrillator (ICD) implantation, ventricular defibrillation testing (DFT) is considered a standard procedure. This procedure often requires multiple ventricular fibrillation (VF) inductions. These repeated short episodes of circulatory arrest with global cerebral ischemia may cause neurological damage. In the present study, patients undergoing initial ICD implantation and limited induction of VF for defibrillation safety margin testing were evaluated for pre- and postoperative cognitive and neurologic functions. In addition, the serum neuron specific enolase (NSE) level, which is a biochemical marker of cerebral injury, was evaluated. The study was performed on 16 patients undergoing initial elective transvenous insertion of an ICD. A neurologic examination and cognitive assessment tests were performed 24 to 48 hours before and after ICD. NSE was determined before (NSE 1) and at the end of the surgery (NSE 2), as well as 2 hours (NSE 3), 24 hours (NSE 4), and 48 hours (NSE 5) after implantation. A total of 29 internal shocks (average, 1.8 ± 0.4) with energy ranging from 14 to 41 J (mean, 20 ± 5; median, 20 J ) were delivered in the ICD group patients. In one patient, 3 external (50, 200 and 360 J) shocks were required for fast VT induced during ICD lead positioning. The mean duration of VF was 10 ± 4 seconds and the mean cumulative time in VF was 16 ± 5 seconds. The mean recovery time between VFs was 5.3 ± 0.6 minutes. NSE levels were not different from the baseline at any time point in the patients of the group that completed the 48-hour observation period (P > 0.05). The patients did not report any new neurological symptoms after ICD implantation, and repeat examination after the procedure showed no abnormal findings other than those detected in the previous one. There were no statistically significant differences between the preoperative and postoperative scores obtained in the cognitive assessment. Single or two VF inductions and the brief arrest of cerebral circulation during ICD implantation are not associated with permanent neurological injury. However, further studies are needed to confirm this finding.